AcidoCEST-UTE MRI Reveals an Acidic Microenvironment in Knee Osteoarthritis
- PMID: 35457284
- PMCID: PMC9027981
- DOI: 10.3390/ijms23084466
AcidoCEST-UTE MRI Reveals an Acidic Microenvironment in Knee Osteoarthritis
Erratum in
-
Correction: Lombardi et al. AcidoCEST-UTE MRI Reveals an Acidic Microenvironment in Knee Osteoarthritis. Int. J. Mol. Sci. 2022, 23, 4466.Int J Mol Sci. 2023 Aug 2;24(15):12346. doi: 10.3390/ijms241512346. Int J Mol Sci. 2023. PMID: 37569908 Free PMC article.
Abstract
A relationship between an acidic pH in the joints, osteoarthritis (OA), and pain has been previously demonstrated. Acidosis Chemical Exchange Saturation Transfer (acidoCEST) indirectly measures the extracellular pH through the assessment of the exchange of protons between amide groups on iodinated contrast agents and bulk water. It is possible to estimate the extracellular pH in the osteoarthritic joint using acidoCEST MRI. However, conventional MR sequences cannot image deep layers of cartilage, meniscus, ligaments, and other musculoskeletal tissues that present with short echo time and fast signal decay. Ultrashort echo time (UTE) MRI, on the other hand, has been used successfully to image those joint tissues. Here, our goal is to compare the pH measured in the knee joints of volunteers without OA and patients with severe OA using acidoCEST-UTE MRI. Patients without knee OA and patients with severe OA were examined using acidoCEST-UTE MRI and the mean pH of cartilage, meniscus, and fluid was calculated. Additionally, the relationship between the pH measurements and the Knee Injury and Osteoarthritis Outcome Score (KOOS) was investigated. AcidoCEST-UTE MRI can detect significant differences in the pH of knee cartilage, meniscus, and fluid between joints without and with OA, with OA showing lower pH values. In addition, symptoms and knee-joint function become worse at lower pH measurements.
Keywords: CEST; MRI; OA; UTE; cartilage; chemical exchange saturation transfer; meniscus; osteoarthritis; pH; ultrashort echo time.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7. - DOI - PMC - PubMed
-
- Jin Z., Wang D., Zhang H., Liang J., Feng X., Zhao J., Sun L. Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: Results from the global burden of disease study 2017. Ann. Rheum. Dis. 2020;79:1014–1022. doi: 10.1136/annrheumdis-2020-217050. - DOI - PubMed
-
- Quicke J.G., Conaghan P.G., Corp N., Peat G. Osteoarthritis year in review 2021: Epidemiology & therapy. Osteoarthr. Cartil. 2022;30:196–206. - PubMed
MeSH terms
Grants and funding
- R01 AR068987/AR/NIAMS NIH HHS/United States
- R01 AR079484/AR/NIAMS NIH HHS/United States
- R21 AR075851/AR/NIAMS NIH HHS/United States
- N/A/GE Healthcare
- R01AR068987/NH/NIH HHS/United States
- R01AR078877/NH/NIH HHS/United States
- I01RX002604/United States Department of Veterans Affairs
- R01 AR062581/AR/NIAMS NIH HHS/United States
- T32EB005970/NH/NIH HHS/United States
- R01 AR078877/AR/NIAMS NIH HHS/United States
- R01AR075825/NH/NIH HHS/United States
- I01CX001388/United States Department of Veterans Affairs
- I01 RX002604/RX/RRD VA/United States
- R01 AR075825/AR/NIAMS NIH HHS/United States
- R21AR075851/NH/NIH HHS/United States
- R01AR062581/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
